National Health (Residential Medication Chart) Amendment Determination 2012 (No. 2) (No. PB 101 of 2012)

Overview

The National Health (Residential Medication Chart) Amendment Determination 2012 (No.2) was enacted to correct drafting errors in the initial National Health (Residential Medication Chart) Determination 2012 and its first amendment (PB 59 of 2012). These errors were identified and required rectification to ensure the accurate application of the provisions under section 93A of the National Health Act 1953, which pertains to the supply of pharmaceutical benefits to prescribed institutions, specifically residential care services as defined under the Aged Care Act 1997. The amendment was made under the authority granted by subsection 93A (2) of the National Health Act 1953, with the policy objective of ensuring the efficient and accurate administration of the Pharmaceutical Benefits Scheme (PBS) to support the progressive realisation of the right to the highest attainable standard of physical and mental health as recognised by the International Covenant on Economic, Social and Cultural Rights. This legislative instrument was developed to amend the National Health (Residential Medication Chart) Determination 2012 by inserting the title “2.11 Standard fields information – pharmaceutical benefits: short-term medicines” at Section 2.11, correcting the number to “(4)” at Subsection 2.13(4), and adding a closing quotation mark to the word ‘Ongoing’ at Subparagraph 2.14 (b) (viii). The changes were minor and mechanical, hence no formal consultation process was undertaken. This amendment was made to ensure the PBS operates smoothly and effectively, thereby supporting the broader human rights framework by facilitating access to necessary medications for residential care services.

Scope and Application

The National Health (Residential Medication Chart) Amendment Determination 2012 (No.2) amends the National Health (Residential Medication Chart) Determination 2012 to correct drafting errors in the original Determination and its first amendment, both of which commenced on 21 August 2012. This instrument applies to pharmaceutical benefits that may be supplied under section 93A of the National Health Act 1953 to prescribed institutions, specifically residential care services defined under the Aged Care Act 1997. The amendments aim to ensure that the conditions for the supply of these pharmaceutical benefits are correctly articulated, thereby facilitating the efficient and effective administration of the Pharmaceutical Benefits Scheme (PBS) within these institutions. The regulation is applicable nationally and operates within the framework established by the National Health Act 1953. There are no exclusions, exemptions, or thresholds specified in this determination, and its scope is limited to the corrections of specific drafting errors without introducing new substantive changes. This legislative instrument is compatible with human rights as it supports the provision of subsidised access to medicines, thereby advancing the right to the highest attainable standard of physical and mental health as recognised in the International Covenant on Economic, Social and Cultural Rights.

Key Provisions

The National Health (Residential Medication Chart) Amendment Determination 2012 (No. 2) (the Instrument) amends the National Health (Residential Medication Chart) Determination 2012, primarily to correct drafting errors. Section 2.11 is re-titled to “2.11 Standard fields information – pharmaceutical benefits: short-term medicines”, subsection 2.13(4) has the number ‘(4)’ re-inserted, and a closing quotation mark is added to the word ‘Ongoing’ at subparagraph 2.14 (b) (viii). These changes aim to ensure the accuracy and clarity of the original Determination, which specifies the pharmaceutical benefits that can be supplied to residential care services under section 93A of the National Health Act 1953, and the conditions necessary for such supply. The Instrument imposes specific obligations on parties involved in the supply of pharmaceutical benefits to residential care services. These obligations include ensuring that the residential medication chart complies with the corrected provisions outlined in the Determination. Pharmaceutical benefits must be supplied in accordance with the amended requirements, which include the accurate description of short-term medicines and the correct formatting of ongoing medication details. These amendments are crucial for maintaining the integrity of the medication supply process and ensuring that residential care services can effectively manage the health needs of their residents. Failure to comply with the corrected provisions of the Determination could result in administrative or legal consequences. Although the Instrument does not explicitly state penalties for non-compliance, breaches of the National Health Act 1953 or its regulations could lead to enforcement actions by the relevant authorities. Potential outcomes include fines, corrective orders, or other regulatory measures to ensure adherence to the Act’s requirements. The severity of penalties would depend on the nature and extent of the non-compliance, as well as any associated harm caused to patients or residents. This Instrument is designed to ensure that the National Health (Residential Medication Chart) Determination 2012 functions as intended, with clear and precise guidelines for the supply of pharmaceutical benefits to residential care services. By correcting previous drafting errors, the Instrument helps to uphold the standards required under the National Health Act 1953, thereby protecting the health and well-being of individuals in residential care. The amendments reflect a commitment to maintaining efficient and accurate operational arrangements within the Pharmaceutical Benefits Scheme (PBS), which is essential for the effective administration of the Scheme and the advancement of public health objectives.